Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-05 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote : 30 novembre 2022
|
French | 174.1 KB | ||
| 2022-12-05 18:00 |
VALNEVA - Declaration of shares and voting rights: November 30, 2022
|
English | 61.6 KB | ||
| 2022-12-05 07:00 |
Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chi…
|
English | 169.2 KB | ||
| 2022-12-05 07:00 |
Valneva annonce des données positives à douze mois sur la persistance des antic…
|
French | 194.5 KB | ||
| 2022-12-01 07:00 |
Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and A…
|
English | 178.8 KB | ||
| 2022-12-01 07:00 |
Valneva et Pfizer annoncent des données à six mois sur la persistance des antic…
|
French | 175.9 KB | ||
| 2022-11-29 18:00 |
Valneva organise une journée investisseurs à New York
|
French | 109.8 KB | ||
| 2022-11-29 18:00 |
Valneva to Host Investor Day in New York City
|
English | 133.3 KB | ||
| 2022-11-17 07:00 |
Valneva annonce la nomination de Dipal Patel en tant que Chief Commercial Offic…
|
French | 110.2 KB | ||
| 2022-11-17 07:00 |
Valneva Appoints Dipal Patel as Chief Commercial Officer
|
English | 116.2 KB | ||
| 2022-11-10 07:00 |
Valneva publie ses résultats financiers pour les neuf premiers mois de l’exerci…
|
French | 340.3 KB | ||
| 2022-11-10 07:00 |
Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates
|
English | 344.6 KB | ||
| 2022-11-07 17:45 |
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcar…
|
English | 106.6 KB | ||
| 2022-11-07 17:45 |
Valneva fera une présentation et participera à des réunions investisseurs lors …
|
French | 107.3 KB | ||
| 2022-11-04 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote : 31 octobre 2022
|
French | 174.4 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
